Biote earnings were $5.9M for the trailing 12 months ending Jun 30, 2026, with -83.8% growth year over year. The latest BTMD earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$6.6M, down 388.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, BTMD reported annual earnings of $27.0M, with 756.7% growth.
BTMD past earnings growth
How has BTMD's earnings growth performed historically?
On BTMD's earnings call on Aug 5, 2026, Biote (NASDAQ: BTMD) reported Q2 2026 earnings per share (EPS) of -$0.23, up 330% year over year. Total BTMD earnings for the quarter were -$6.56 million. In the same quarter last year, Biote's earnings per share (EPS) was $0.10.
As of the last Biote earnings report, Biote is currently profitable. Biote's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $5.86 million, a 81.3% decrease year over year.
What was BTMD's earnings growth in the past year?
As of Biote's earnings date in Aug 5, 2026, Biote's earnings has grown -83.84% year over year. This is 133.66 percentage points lower than the US Medical Care Facilities industry earnings growth rate of 49.82%. BTMD earnings in the past year totalled $5.86 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.